Decisional algorithm to prescribe vitamin K antagonist in geriatric patients with atrial fibrillation;Algorithme décisionnel pour la prescription d'antivitamine K dans la fibrillation atriale du patient gériatrique

Geriatrie et Psychologie Neuropsychiatrie du Vieillissement

Volumn 12, Issue 1, 2014, Pages 20-24

  Sibai, Mehdi Sylvain ^a   Bellarbre, Fabienne ^a   Ghazali, Nisrin ^a   Bureau, Marie Laure ^a   Priner, Mathieu ^a   Ingrand, Pierre ^b,c   Paccalin, Marc ^a  

^a Pôle de Gériatrie ^*  (France)

^b HÔpital Européen Georges Pompidou   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

Algorithm; Atrial fibrillation; Geriatrics; Vitamin K antagonists

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; VITAMIN K GROUP;

AGED; ALGORITHM; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; FEMALE; GERIATRICS; HEART ATRIUM FIBRILLATION; HUMAN; MALE; RISK FACTOR; VERY ELDERLY; VITAMIN K ANTAGONISTS;

ALGORITHM; ATRIAL FIBRILLATION; GERIATRICS; VITAMIN K ANTAGONISTS;

AGED; AGED, 80 AND OVER; ALGORITHMS; ANTICOAGULANTS; ATRIAL FIBRILLATION; FEMALE; FIBRINOLYTIC AGENTS; HEMORRHAGE; HUMANS; MALE; RISK FACTORS; STROKE; VITAMIN K;

EID: 84897977369     PISSN: 21158789     EISSN: 21157863     Source Type: Journal    
DOI: 10.1684/pnv.2014.0458     Document Type: Article

References (23)

1. Heeringa J, van der Kuip DAM, Hofman A, Kors JA, van Herpen G, Stricker BHC, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 2006; 27: 949-53.
2. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (Atria) Study. JAMA 2001; 285: 2370-5.
3. Nieuwlaat R, Prins MH, Le Heuzey J, Vardas PE, Aliot E, Santini M, et al. Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro heart survey on atrial fibrillation. Eur Heart J 2008; 29: 1181-9.
4. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 1991; 22: 983-8.
5. Lin HJ, Wolf PA, Kelly-Hayes M, Beiser AS, Kase CS, Benjamin EJ, et al. Stroke severity in atrial fibrillation. The Framingham study. Stroke 1996; 27: 1760-4.
6. Marini C, De Santis F, Sacco S, Russo T, Olivieri L, Totaro R, et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke 2005; 36: 1115-9.
7. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146: 857-67.
8. Mant J, Hobbs FDR, Fletcher K, Roalfe A, Fitzmaurice D, Lip GYH, et al.Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007; 370: 493-503.
9. Camm AJ, Lip GYH, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012; 33: 2719-47.
10. Peterson GM, Boom K, Jackson SL, Vial JH. Doctor's beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention. Intern Med J 2002; 32: 15-23.
11. Monte S, Macchia A, Pellegrini F, Romero M, Lepore V, D'Ettorre A, et al. Antithrombotic treatment is strongly underused despite reducing overall mortality among high-risk elderly patients hospitalized with atrial fibrillation. Eur Heart J 2006; 27: 2217-23.
12. Castot A, Haramburu F, Kreft-Jaïs C. Etude EMIR (effets indésirables des médicaments (incidences et risques). Site connecté le 28 août 2013. http://agmed.sante.gouv.fr/pdf/1/fiche- presse-avk-emir.pdf.
13. Landefeld CS, Goldman L. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. Am J Med 1989; 87: 144-52.
14. Kagansky N, Knobler H, Rimon E, Ozer Z, Levy S. Safety of anticoagulation therapy in well-informed older patients. Arch Intern Med 2004; 164: 2044-50.
15. Buatois S, Perret-Guillaume C, Gueguen R, Miget P, Vançon G, Perrin P, et al. A simple clinical scale to stratify risk of recurrent falls in community-dwelling adults aged 65 years and older. Phys Ther 2010; 9: 550-60.
16. Rozzini R, Frisoni GB, Ferruci L, Barbisoni P, Sabatini T, Ranieri P, et al. Geriatric index of comorbidity: validation and comparaison with other measures of comorbidity. Age Ageing 2002; 31: 277-85.
17. Cohen N, Almoznino-Sarafian D, Alon I, Gorelik O, Koopfer M, Chachashvily S, et al. Warfarin for stroke prevention still underused in atrial fibrillation: patterns of omission. Stroke 2000; 31: 1217-22.
18. Friberg L, Hammar N, Ringh M, Pettersson H, Rosenqvist M. Stroke prophylaxis in atrial fibrillation: who gets it and who does not ? Report from the Stockholm cohort-study on atrial fibrillation (SCAF-study). Eur Heart J 2006; 27: 1954-64.
19. Haïda N, Albouy-Llaty M, Baudemont C, Bellarbre F, Paccalin M. Adequacy between prescriptions and CHADS(2) score recommendations in geriatric patients. Geriatr Psychol Neuropsychiatr Vieil 2011; 9: 39-44.
20. Poli D, Antonucci E, Grifoni E, Abbate R, Gensini GF, Prisco D. Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years. J Am Coll Cardiol 2009; 54: 999-1002.
21. VanWalraven C, Hart RG, Singer DE, Laupacis A, Connolly S, Petersen P, et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA 2002; 288: 2441-8.
22. Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S. Major hemorrhage and tolerability ofwarfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 2007; 115: 2689-96.
23. Hanley JP. Warfarin reversal. J Clin Pathol 2004; 57: 1132-9.